SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-051316
Filing Date
2017-09-05
Accepted
2017-09-05 16:34:36
Documents
1
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1599
  Complete submission text file 0001209191-17-051316.txt   2925
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
MacLean Michael F (Reporting) CIK: 0001383731 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38137 | Film No.: 171069115

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations